• Home
  • Company Profile
  • News
  • Products
  • Cart
  • Checkout
  • My Account
  • Terms & Conditions
  • Privacy Policy
Paragon BioTeck, Inc.Paragon BioTeck, Inc.
  • HOME
  • ABOUT
    • Company Profile
    • Business Integrity
  • PRODUCTS
    • Diagnostics
      • Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% 15 mL
      • Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% 10mL
      • Phenylephrine Hydrochloride Ophthalmic Solution USP 10% 5mL
  • NEWS
  • CONTACT

Bullseye: January Link Round Up

Home » News » Bullseye: January Link Round Up

Bullseye: January Link Round Up

01/31/2017 Eye Health

One month into 2017 and the eye care industry has hit the ground running. Here are just a few articles that caught our eye this month.

    • The sneakiness of glaucoma symptoms makes its early detection imperative—without it, treatment may come too late to save a patient’s eyesight. As Glaucoma Awareness Month comes to a close, the American Optometric Association is looking forward to a new diagnosis tool that allows doctors to see the cells most responsible for the loss of vision in glaucoma patients and potentially detect the disease sooner than is currently possible. Read on AOA: New technique could diagnose glaucoma sooner
    • Contact lens wearers are five times more likely to complain about dry eye symptoms than those who wear glasses and 12 times more likely than people who don’t need corrective lenses1. The dry ocular surface created by contact lenses can contribute to the risk of other infections as well, but these simple tips from Allure can help offset some of that risk. Read on Allure: 9 Gross Things Every Contact Lens Wearer Seriously Needs To Know
    • Are robots the future of eye surgery? With new, tiny technology, doctors are able to perform surgery with more precision than ever and are looking forward to expanding the potential applications. Read on MIT: The Tiny Robots Revolutionizing Eye Surgery
    • In a trial published in Ophthalmology, Charles C. Wykoff, M.D., Ph.D., from Houston Methodist Hospital in Texas, along with his colleagues, investigated the efficacy of fluocinolone implants in patients with diabetic retinopathy. While anti-VEGF injections appear to be more effective at reducing the severity of the disease, the high number of injections and clinic visits required by that treatment may not be possible for some patients. Fluocinolone implants were found to slow the progression of diabetic retinopathy at a similar rate of an anti-VEGF treatment while requiring only 1-2 injections over three years. Login to Medscape to read: Fluocinolone Implant Slows Diabetic Retinopathy in Patients With Macular Edema
    • According to the website for See Now, an organization working to end avoidable blindness, “4 out of 5 people who are blind don’t need to be.” Despite that fact, over 4 million people in the United States suffer from vision loss or blindness2 and most causes of vision loss are treatable or preventable. Prevent Blindness America and See Now have partnered in an exciting initiative to secure federal funds to support eye health in the United States. Read on Eyewire Today: Prevent Blindness and See Now Partner to Stop Growing Number of People Living with Preventable Vision Loss

Citations:

  1. Dan Fuller, OD ”Yes, Dry Eye Patients Can Wear Contacts.” Review of Optometry. August 15, 2015.
  2. ”Vision Problems in the U.S..” Prevent Blindness. 2012 .
Share
0

You also might be interested in

Paragon BioTeck, Inc. Announces Call for 2018 Koch Kellan Scholarship Applicants

Oct 2, 2017

The Koch Kellan Scholarship honors a graduate medical student pursuing[...]

Xinxin Zhang shares her experience at ASCRS•ASOS

Jun 12, 2017

2017 Koch Kellan Scholar, Xinxin Zhang, was formally presented with her scholarship award at a ceremony held on Sunday, May 7. Ms. Zhang was invited to attend the 2017 ASCRS•ASOS annual meeting in Los Angeles on behalf of Paragon BioTeck where she had the opportunity to explore the conference and meet ophthalmic industry leaders. Read on to hear her thoughts about the conference and ceremony.

5 Questions: 2017 Koch Kellan Scholar Xinxin Zhang

May 23, 2017

Each year, Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to a third-year ophthalmology student. The scholarship, named for two pillars of the eye care industry — Paul Koch, MD, and Robert Kellan, MD — highlights rising stars who share our dedication to underserved medical needs. This year, we are proud to introduce our 2017 Koch Kellan Scholar: Xinxin Zhang. We caught up with her after the announcement to learn more about her exciting work and future plans.

RECENT POSTS

  • Paragon BioTeck Reformulated FRESHKOTE®, Prompting Eyevance Acquisition 09/14/2018
  • Paragon BioTeck, Inc. Hosts Pearl Buck Preschool Holiday Event 12/01/2017
  • Paragon BioTeck, Inc. Announces Call for 2018 Koch Kellan Scholarship Applicants 10/02/2017
  • Talking to Patients About Eye Health 08/24/2017
  • Xinxin Zhang shares her experience at ASCRS•ASOS 06/12/2017

Newsletter Sign-Up

  • This field is for validation purposes and should be left unchanged.

HOME

Contact Us
News

PRODUCTS

Diagnostics

ABOUT

Company Profile
Business Integrity

CUSTOMER SERVICE

1-888-424-1192
customercare@paragonbioteck.com

© 2017 Paragon BioTeck, Inc. All Rights Reserved.

Privacy Policy | Return Policy | Terms of Use | Social Media Guidelines


Prev Next